Resources

Cannabis and Heart Health: What Research Shows in GA

Explore cannabis and heart health in GA: short-term heart-rate findings, mixed blood-pressure results, and limits on claims about long-term heart harm.

By Tim FrancisPublished
A blank notebook, pen and unbranded blood pressure cuff on a sunlit wooden table.

Cannabis and heart health research points most clearly to a faster heart rate soon after use. A systematic review, which brings studies together, found low-strength evidence for that change. It found too little evidence to settle short-term blood-pressure changes or changes in blood flow in the brain. Acute means short-term, which was the focus of the review.

A fast pulse, a blood-pressure change, and heart disease are not the same outcome. Each needs its own answer. That distinction can help when you feel worried about your own use or someone you love.

What has research found about cannabis and heart rate?

Cannabis was linked with a faster heart rate in all 14 short-term studies the review assessed. Confidence in that finding was low. Addiction treatment addresses drug-use needs, while physical health care remains a distinct part of planning. Outpatient addiction support does not replace medical assessment of heart concerns.

The review calls this fast heart rate tachycardia. The finding did not come only from studies with major flaws. Two trials that the authors rated at low risk of bias also found a rise. Those trials included THC given through smoke, by mouth, or by injection. The review still rated the overall evidence low strength.

These were studies in which researchers gave a substance and measured the response. They were not just reports of one person's illness. THC, the part of cannabis that causes the high, was central to the exposures studied. MedlinePlus explains THC's role, and the review describes the study methods.

Some studies also found that heart rate rose with the dose. The review reported this pattern in two randomized trials and two other studies. That adds detail beyond whether a pulse changed at all. It does not provide a dose rule for everyday use. The findings came from specific study exposures, not every product or use pattern.

“All 14 studies” refers to study findings, not a promise that every person responds alike. Nor is a rise in pulse a count of heart attacks. The researchers measured short-term body responses. Their review did not follow people for years to count later heart disease.

What does research show about blood pressure and brain blood flow?

The review found mixed blood-pressure results, not one clear direction of change. It also found too little evidence about blood flow in the brain. Treatment matched to a person's needs considers drug use and health concerns. Clear roles for each provider keep those needs from being confused.

Six studies examined blood pressure. Two reported a drop in systolic pressure, the top blood-pressure number. Of the other four, three found no effect and one found a rise. The authors judged the evidence insufficient. That means the studies did not support a firm conclusion about the short-term change, according to the review's blood-pressure results.

A faster heart rate does not fill this gap. The same review reached different conclusions for heart rate and blood pressure. Treating both as a single finding would hide the mixed results. Each measure needs its own assessment of the evidence.

Short-term cannabis findings: what changed and how firm the answer was
MeasureWhat studies reportedReview conclusion
Heart rateAll 14 studies linked use with a faster heart rate.Low-strength evidence for an increase. Heart-rate findings
Blood pressureSix studies found decreases, no effect, or an increase.Insufficient evidence about short-term changes. Blood-pressure findings
Blood flow in the brainTwo studies used different measures and had different results.Insufficient evidence about short-term changes. Brain blood-flow findings

The two brain studies did not measure quite the same thing. One found a drop in the speed of blood flow. The other found no change in overall blood flow in the brain. The review describes these as circulation measures. They are not counts of strokes or proof that a stroke followed a measured change.

Do short-term findings prove long-term heart harm?

No. The short-term review did not establish long-term heart disease. MedlinePlus separately links heavy long-term use with a higher risk of heart problems. Choosing addiction care and planning other medical care are related but different tasks. A drug-use concern does not settle the cause of a heart condition.

A link means that use and a health problem have been connected in research. It is not the same as proof of cause and effect. MedlinePlus reports the link to heart problems but gives no personal risk estimate. Its statement should not become a claim that cannabis inevitably causes heart disease, heart attack, or stroke. That would go beyond the reported long-term link.

The sources also address different time frames. The review asks what changed soon after researchers gave cannabis or THC. MedlinePlus gives a broader health summary that includes heavy long-term use. A short-term measurement cannot answer a question about disease years later. This distinction follows from the review's scope and the MedlinePlus summary.

Daily use raises a separate concern. Cannabis can be addictive, and MedlinePlus calls that addiction cannabis use disorder. It says people who use every day are more likely to become addicted. Stronger products also raise addiction risk. These are findings about addiction, not a formula for predicting heart disease.

The distinction matters without making either concern less important. The daily-use statement concerns addiction. The heavy long-term-use statement concerns links to health problems. MedlinePlus reports both, but it does not equate them. A person can need help with drug use and also need separate care for physical health.

How do cannabis products and routes affect the evidence?

Effects vary with the product and how you take it, according to MedlinePlus. The review mostly tested smoked or inhaled cannabis. Substance-use care should reflect actual use patterns, while physical health planning accounts for other medical needs. A product label alone cannot fill either role.

Routes include smoking, vaping, eating or drinking cannabis, and placing drops under the tongue. People also apply some products to the skin. These are different ways of using cannabis, not proof of equal heart effects. MedlinePlus lists the routes; the review did not compare them all on equal terms.

Twelve of the 14 studies used smoking or inhalation. The authors also noted that the THC levels studied were lower than those in products sold when they wrote the review. They called for more safety data on higher THC levels. That limits how well these older exposures fit a broader product range.

MedlinePlus names several factors that can affect a response:

  • Amount, frequency, THC level, and other ingredients
  • Route, past cannabis use, age, and sex
  • Other drugs or medicines and existing health conditions

THC and CBD are also not the same chemical. THC causes a high; CBD does not, according to MedlinePlus. But a statement about a high is not a heart-safety finding. The THC-focused short-term review does not establish that a CBD label makes a product safe for the heart.

Very high doses pose another concern. MedlinePlus says a cannabis overdose can occur and may include a rapid heartbeat, anxiety, or panic. This is a separate warning about overdose. It should not be confused with a claim that every faster pulse in the short-term studies was an overdose.

Neither the list of routes nor the study results ranks every product for heart safety. An edible avoids the act of smoking, but that alone does not answer a heart-health question. The review's limited route comparisons do not support a blanket claim that one route prevents heart effects.

Why are older studies of young, healthy people hard to apply?

The review's studies mostly involved young, healthy people and used older products. Those limits matter when applying results to other adults. A needs-based treatment plan starts with the person, not an average study result. Coordination with other clinicians also keeps existing health care separate from an addiction program's services.

The search covered studies published from January 1, 1975, through March 31, 2018. That end date matters. It marks the review's search window, not the end of all cannabis research. The authors acknowledged that their time limits could leave out relevant work. The review therefore should not stand in for all later findings.

The study methods also shaped confidence:

  • Seven studies were randomized trials; seven were not.
  • Half the studies had a high risk of bias.
  • The studies generally enrolled young, healthy people.

Randomized means chance helps assign people to study groups. Bias means flaws may skew a result. A review weighs these features rather than just counting studies. Fourteen studies pointing toward a faster pulse can still leave low confidence in the overall finding. That is why the authors' quality rating belongs beside the result, not out of sight.

The participants matter too. Results from mostly young, healthy people do not settle effects in older adults or those with existing disease. The authors specifically called for data from people with a wider range of health needs. They also sought more data on higher THC levels. These were named gaps in the review, not reasons to dismiss its findings.

Care has a different starting point from a study average. Addiction treatment selection considers the substance, use pattern, and other needs. Medical-care coordination clarifies which provider handles which concern. An existing health need should not disappear when addiction care starts. Nor does outpatient treatment mean every physical health service is available on site.

River City Recovery provides adult outpatient addiction support in Columbus, GA, not cardiology or onsite detox. For program information, call 706-617-4970 or use the contact page. This contact is for addiction-service information, not an assessment of heart symptoms or a promise of admission.

Frequently asked questions

Does cannabis increase heart rate?

A review found that all 14 short-term studies linked cannabis use with a faster heart rate. The authors rated the evidence low strength. This means the finding deserves attention, but study quality limits confidence. It does not mean every person had the same response or that a faster pulse proves heart disease. Sources: PMC; MedlinePlus.

Can cannabis raise or lower blood pressure?

The six blood-pressure studies had mixed results. Some found a drop, others found no effect, and one found a rise. The review judged the evidence insufficient to settle short-term blood-pressure changes. Its clearer finding about heart rate should not be used to assume that blood pressure changes in the same way. Sources: PMC; MedlinePlus.

Do short-term studies prove that cannabis causes heart disease?

No. The review measured short-term changes, not heart disease over years. MedlinePlus separately reports a link between heavy long-term use and a higher risk of heart problems. That link is a reason for concern, but it does not prove cause and effect or give a personal risk estimate. Sources: PMC; MedlinePlus.

Are edibles safer than smoking for heart health?

The review does not establish that. Most included studies used smoking or inhalation, so they do not provide an equal comparison of all routes. MedlinePlus says effects vary with route, amount, THC level, and other factors. Avoiding smoke alone does not prove that a product prevents heart effects. Sources: PMC; MedlinePlus.

Does daily cannabis use predict heart problems?

These sources do not provide a personal heart-risk forecast based on daily use. MedlinePlus says daily use makes addiction more likely, which is a separate concern. It also reports a link between heavy long-term use and heart problems. The addiction finding and the heart-health link should not be treated as the same result. Sources: PMC; MedlinePlus.

By Tim Francis, SUD Content Specialist. Reviewed by clinical staff.

Talk with our team

Contact River City Recovery for more information.

Call (706) 617-4970